Previous Page  4 / 6 Next Page
Information
Show Menu
Previous Page 4 / 6 Next Page
Page Background

Volume 10

Journal of Cancer Science & Therapy

Oncologists 2018

May 24-25, 2018

Page 15

Notes:

conference

series

.com

May 24-25, 2018 Osaka, Japan

22

nd

Global Annual Oncologists Meeting

Multiple roles of the cytoskeletal protein, gelsolin, in gastrointestinal tumor cells that contribute to

dissemination and tumor progression

G

elsolin is an actin-binding protein which regulates the dynamics of the actin cytoskeleton and is involved in several

pathological conditions including cancer. The roles of gelsolin in cancer are complex, there is evidence that it contributes

to both tumor suppression as well as malignant progression. Studies suggest that gelsolin can act as a tumor suppressor, with

decreased expression of gelsolin observed in cancers such as breast and lung cancers. On the other hand, high gelsolin expression

has been correlated with aggressive tumors, such as with high grade urothelial and oral carcinomas, and lymphatic invasion in

lung cancer. We identified gelsolin expression to be up-regulated in tumor tissues which exhibit disseminative behavior, such

in lymph node metastases of intestinal-type gastric cancer, in primary tumors of diffuse gastric cancer and at the invasive edges

of colon cancer metastases in the liver. We found that gelsolin can promote dissemination of gastrointestinal cancer cells by

several mechanisms-gelsolin dysregulates the cellular redox milieu and promotes extracellular matrix degradation, leading to

increased invasive activity of cancer cells. Gelsolin also interacts with the Hepatocyte Growth Factor (HGF)-cMET pathway

and affects intercellular adhesion to promote cell scattering. In addition, gelsolin protects cancer cells from stress by activating

autophagy. The multiple roles of gelsolin that contribute to cancer progression will be discussed.

Biography

Celestial T. Yap has obtained MBBS degree from the National University of Singapore. She is engaged in clinical practice and subsequently obtained a PhD in

Biomedical Sciences at the University of Edinburgh, UK. She is the Physiology Program Director and the Integration Lead Educator at the Yong Loo Lin School of

Medicine, NUS, overseeing undergraduate education in clinical sciences. She leads the cytoskeleton and tumor biology laboratory, which focuses on cytoskeletal

derangements and signaling pathways that promote tumor invasion and resistance, as well as biomarkers for cancer detection.

phsyapc@nus.edu.sg

Celestial T. Yap

National University of Singapore, Singapore

Celestial T. Yap, J Cancer Sci Ther 2018, Volume 10

DOI: 10.4172/1948-5956-C3-128